Tocqueville Asset Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Tocqueville Asset Management’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-11,650	Closed	-$382K	–	870
2016 Q3	$382K	Sell	11,650 -9,000	-44%	-$274K	﹤0.01%	669
2016 Q2	$516K	Sell	20,650 -900	-4%	-$24.4K	0.01%	629
2016 Q1	$528K	Buy	21,550 +14,925	+225%	+$346K	0.01%	619
2015 Q4	$219K	Sell	6,625 -15,000	-69%	-$507K	﹤0.01%	832
2015 Q3	$708K	Buy	21,625 +8,125	+60%	+$345K	0.01%	623
2015 Q2	$715K	Buy	+13,500	New	+$491K	0.01%	630

Other funds holding ALDR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Tocqueville Asset Management's ALDR Position: Q4 2016 in Review

Tocqueville Asset Management sold out of Alder Biopharmaceuticals (ALDR) in Q4 2016, closing a stake of 11,650 shares — an estimated $382K sold.

Tocqueville Asset Management first reported a position in ALDR in Q2 2015 and held it in 6 quarters. The position peaked at $715K in Q2 2015. 145 funds tracked by Wall St. Rank hold ALDR as of Q4 2016.

Tocqueville Asset Management reported no remaining Alder Biopharmaceuticals position as of Q4 2016 after selling out during the quarter.
Tocqueville Asset Management sold 11,650 Alder Biopharmaceuticals shares in Q4 2016, an estimated $382K.
Tocqueville Asset Management first reported a position in Alder Biopharmaceuticals in Q2 2015 and held it in 6 quarters.
Tocqueville Asset Management's Alder Biopharmaceuticals position peaked at $715K in Q2 2015.
145 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2016.

Based on Tocqueville Asset Management's 13F filing for Q4 2016, filed 30 Jan 2017.